Obesity

Obesity: the prevention, identification, assessment and management of overweight and obesity in adults and children

Summary

CG43 Obesity replaces the following pieces of guidance:

• TA22 Obesity - orlistat
• TA31 Obesity - sibutramine
• TA46 Obesity (morbid) - surgery

Amendment to Understanding NICE Guidance documents

The Understanding NICE Guidance (UNG) versions 'Preventing obesity and staying a healthy weight' and 'Treatment for people who are overweight or obese' previously referred to The Obesity Awareness and Solutions Trust (TOAST) as a source of additional information and support for people wanting to stay a healthy weight or to lose weight. Please note that this organisation closed in December 2007 and is no longer able to provide such information and support, and so reference to the organisation has been removed. The remaining organisations listed in the UNG documents are still able to offer information about preventing or treating obesity.

Guidance documents

• NICE Guidance PDF format  | MS Word format
• CG43 Obesity: full guideline
• CG43 Obesity: quick reference guide 1 for local authorities, schools and early years providers, workplaces and the public.
• CG43 Obesity: quick reference guide 2 for the NHS
• CG43 Obesity: full guideline (MS Word format)
• CG43 Obesity: understanding NICE guidance - treatment for people who are overweight or obese (amended July 2008)
• CG43 Obesity: understanding NICE guidance - preventing obesity and staying a healthy weight (amended July 2008)
• CG43 Obesity: understanding NICE guidance - preventing obesity and staying a healthy weight (MS Word format) (amended July 2008)
• CG43 Obesity: understanding NICE guidance - treatment for people who are overweight or obese (MS Word format) (amended July 2008)

Implementing this guidance

• Cost report
• Costing template
• Slide set
• Audit criteria
• Support tool

• Obesity: presenter slides
• Bariatric surgical service commissioning guide
• Obesity: online educational tool

• How this guidance was produced
• Background information

Expected review date: TBC